AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Stocktitan

Published November 3, 2026 · Updated November 4, 2026

Kailera Therapeutics to Participate in November Investor Conferences - Stock Titan

Read the full story at Stocktitan

Kailera cannot assure you that the forward-looking statements in this press release will prove to be accurate. ... Psychedelic Therapy Trial. Nov.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic press release